Literature DB >> 24500630

Diabetes risk potentially underestimated in youth and children receiving antipsychotics.

Katherine Samaras1, Christoph U Correll2, Alex J Mitchell3, Marc De Hert4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24500630     DOI： 10.1001/jamapsychiatry.2013.4030

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  5 in total

1.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 2.  Diabetes mellitus and severe mental illness: mechanisms and clinical implications.

Authors:  Richard I G Holt; Alex J Mitchell
Journal:  Nat Rev Endocrinol       Date:  2014-12-02       Impact factor: 43.330

Review 3.  Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Authors:  Mohammad M Khan
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

Review 4.  Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.

Authors:  Jiezhong Chen; Xu-Feng Huang; Renfu Shao; Chen Chen; Chao Deng
Journal:  Front Neurosci       Date:  2017-11-21       Impact factor: 4.677

Review 5.  Does Chinese calligraphy therapy reduce neuropsychiatric symptoms: a systematic review and meta-analysis.

Authors:  Kuan-Yu Chu; Chih-Yang Huang; Wen-Chen Ouyang
Journal:  BMC Psychiatry       Date:  2018-03-07       Impact factor: 3.630
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.